Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p
Authors:
Open Access
- 16 December 2019
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 10 (12) , 1-12
Abstract
In this study, we identified a novel circRNA, circ_0002483, and further investigated its functions in the progression and Taxol resistance of NSCLC. We found that circ_0002483 was expressed at low levels in NSCLC tissues and cell lines. Functional assays indicated that circ_0002483 overexpression significantly inhibited NSCLC cell proliferation and invasion in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol. Mechanistically, circ_0002483 was identified to sponge multiple miRNAs including miR-182-5p (also named miR-182), miR-520q-3p, miR-582-3p, miR-587, and miR-655. In addition, circ_0002483 was also demonstrated to regulate the expression of GRB2, FOXO1, and FOXO3, three target genes of miR-182-5p, by sponging miR-182-5p. Circ_0002483 was demonstrated to inhibit NSCLC progression in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol by sponging miR-182-5p to release the inhibition on GRB2, FOXO1, and FOXO3 mRNAs.Keywords
This publication has 31 references indexed in Scilit:
- Taxane anticancer agents: a patent perspectiveExpert Opinion on Therapeutic Patents, 2015
- Investigation of Prognostic Factors Affecting Efficacy in Carboplatin- and Paclitaxel-based First-line Chemotherapies for Advanced Non-small-cell Lung CancerTumori Journal, 2015
- How Taxol/paclitaxel kills cancer cellsMolecular Biology of the Cell, 2014
- Effect of Smac and Taxol on non-small-cell lung cancerActa Biochimica et Biophysica Sinica, 2014
- One size does not fit allNature Reviews Clinical Oncology, 2011
- The role of βIII tubulin in predicting chemoresistance in non-small cell lung cancerLung Cancer, 2010
- Nuclear Factor-κB Inhibition by Parthenolide Potentiates the Efficacy of Taxol in Non–Small Cell Lung Cancer In vitro and In vivoMolecular Cancer Research, 2009
- A Selective Retinoid X Receptor Agonist Bexarotene (Targretin) Prevents and Overcomes Acquired Paclitaxel (Taxol) Resistance in Human Non–Small Cell Lung CancerClinical Cancer Research, 2004
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell LineJapanese Journal of Cancer Research, 1994